Optometrist · San Antonio, TX
NPI
1568467298
Since 2005
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9157 Huebner Rd
San Antonio, TX, 78240
Phone (210) 697-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
2,332 services
Medicare patients, 2024
534
Average age 74
Drug cost, 2024
$1.5M
1,995 prescriptions
Company payments, 2025
$1,698
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Orozco was code 92012 (ophthalmological e&m), 951 times for 369 patients. In total Michael A Orozco billed 2,332 services in 24 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 951 | 369 | $55.12 | $52K |
| 83861 Clinical Chemistry | Office | 400 | 110 | $21.81 | $8,726 |
| 92014 Ophthalmological E&M | Office | 239 | 233 | $74.07 | $18K |
| 65778 Eye | Office | 155 | 97 | $690.20 | $107K |
| 68761 Eye | Office | 124 | 85 | $136.35 | $17K |
| 92133 Computerized Ophthalmic Imaging | Office | 97 | 94 | $21.52 | $2,088 |
| 99213 Office E&M - Established | Office | 77 | 63 | $61.15 | $4,709 |
| 92083 Vision, Hearing, and Speech Services | Office | 72 | 66 | $37.99 | $2,736 |
| 92004 Ophthalmological E&M | Office | 62 | 62 | $68.68 | $4,258 |
| 76514 Ultrasound - Nonspecific | Office | 44 | 41 | $6.50 | $286 |
| 92020 Ophthalmological E&M | Office | 26 | 23 | $15.75 | $410 |
| 92134 Computerized Ophthalmic Imaging | Office | 19 | 19 | $25.23 | $479 |
| 92002 Ophthalmological E&M | Office | 13 | 13 | $44.73 | $581 |
| 92250 Angiography | Office | 12 | 12 | $23.87 | $286 |
By year: 2022 $127K for 1,189 services; 2023 $205K for 1,492 services; 2024 $220K for 2,332 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 400 | 110 | $21.81 | $8,726 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Orozco prescribed most often to Medicare patients was Tobramycin-Dexamethasone (Tobramycin/Dexamethasone), with 204 prescriptions and refills. In total Michael A Orozco wrote 1,995 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 204 | 221 | 184 | $9,184 |
| Loteprednol Etabonate Generic | 201 | 286 | 119 | $47K |
| Bromfenac Sodium Generic | 165 | 201 | 51 | $53K |
| Xiidra Lifitegrast | 158 | 334 | 82 | $219K |
| Cyclosporine Generic | 125 | 297 | 60 | $84K |
| Restasis Cyclosporine | 113 | 230 | 54 | $138K |
| Latanoprost Generic | 103 | 260 | 37 | $1,351 |
| Ketorolac Tromethamine Generic | 89 | 130 | 33 | $4,819 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 89 | 91 | 65 | $1,003 |
| Moxifloxacin Moxifloxacin Hcl | 74 | 74 | 55 | $1,473 |
| Miebo Perfluorohexyloctane/Pf | 65 | 106 | 29 | $56K |
| Fluorometholone Generic | 52 | 61 | 37 | $4,934 |
| Xdemvy Lotilaner | 49 | 73 | 45 | $92K |
| Brimonidine Tartrate Generic | 42 | 92 | 16 | $5,544 |
| Prednisolone Acetate Generic | 42 | 48 | 34 | $1,399 |
Brand drugs: 1,145 claims; generic drugs: 850 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Orozco $1,698 ($1,698 in general payments such as food, travel and fees) from 10 companies. The largest payer was Bausch & Lomb Americas Inc. with $308.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 7 | $308 |
| Oyster Point Pharma, Inc. | 12 | $238 |
| Alcon Vision LLC ALC | 3 | $234 |
| Dompe US, Inc. | 7 | $206 |
| Biotissue Holdings Inc. | 5 | $205 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 7 | $166 |
| Harrow Eye, LLC | 1 | $144 |
| Sight Sciences, Inc. SGHT | 1 | $98.58 |
| Amgen Inc. AMGN | 3 | $63.96 |
| Abbvie Inc. ABBV | 2 | $33.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.